SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-248745
Filing Date
2019-09-19
Accepted
2019-09-18 21:40:56
Documents
4
Period of Report
2019-09-16
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d805202d8k.htm 8-K 30127
2 EX-3.1 d805202dex31.htm EX-3.1 78054
3 EX-10.1 d805202dex101.htm EX-10.1 28319
4 GRAPHIC g805202g89v01.jpg GRAPHIC 10999
  Complete submission text file 0001193125-19-248745.txt   153063
Mailing Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036
Business Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036 212-776-4381
Ovid Therapeutics Inc. (Filer) CIK: 0001636651 (see all company filings)

IRS No.: 465270895 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38085 | Film No.: 191100903
SIC: 2834 Pharmaceutical Preparations